EssilorLuxottica Société anonyme (ESLOY)
USD 139.72
(2.99%)
USD 139.72
(2.99%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 12.65 Billion EUR | 2.83% |
| 2022 | 12.48 Billion EUR | 25.26% |
| 2021 | 9.96 Billion EUR | 24.39% |
| 2020 | 8.01 Billion EUR | -10.61% |
| 2019 | 8.96 Billion EUR | 63.8% |
| 2018 | 5.47 Billion EUR | 70.39% |
| 2017 | 3.21 Billion EUR | 10.53% |
| 2016 | 2.9 Billion EUR | 4.46% |
| 2015 | 2.78 Billion EUR | 20.02% |
| 2014 | 2.31 Billion EUR | 17.55% |
| 2013 | 1.97 Billion EUR | 1.54% |
| 2012 | 1.94 Billion EUR | 20.2% |
| 2011 | 1.61 Billion EUR | 7.48% |
| 2010 | 1.5 Billion EUR | 18.85% |
| 2009 | 1.26 Billion EUR | 2.74% |
| 2008 | 1.23 Billion EUR | 5.55% |
| 2007 | 1.16 Billion EUR | 5.89% |
| 2006 | 1.1 Billion EUR | 12.21% |
| 2005 | 981.55 Million EUR | 2.37% |
| 2004 | 958.83 Million EUR | 4.52% |
| 2003 | 917.39 Million EUR | -1.98% |
| 2002 | 935.93 Million EUR | 8.45% |
| 2001 | 862.99 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 3.23 Billion EUR | -0.11% |
| 2024 Q1 | 3.23 Billion EUR | -50.2% |
| 2023 Q4 | 6.49 Billion EUR | 102.62% |
| 2023 FY | 12.84 Billion EUR | 2.83% |
| 2023 Q1 | 3.13 Billion EUR | -51.04% |
| 2023 Q2 | 6.34 Billion EUR | 102.17% |
| 2023 Q3 | 3.2 Billion EUR | -49.46% |
| 2022 Q2 | 5.93 Billion EUR | 101.8% |
| 2022 FY | 12.48 Billion EUR | 25.26% |
| 2022 Q1 | 2.94 Billion EUR | -48.37% |
| 2022 Q3 | 3.16 Billion EUR | -46.66% |
| 2022 Q4 | 6.4 Billion EUR | 102.43% |
| 2021 Q3 | 2.87 Billion EUR | -29.47% |
| 2021 FY | 9.96 Billion EUR | 24.39% |
| 2021 Q1 | 2.01 Billion EUR | -49.62% |
| 2021 Q2 | 4.07 Billion EUR | 102.49% |
| 2021 Q4 | 5.69 Billion EUR | 98.36% |
| 2020 FY | 8.01 Billion EUR | -10.61% |
| 2020 Q1 | 1.89 Billion EUR | -56.79% |
| 2020 Q2 | 3.78 Billion EUR | 100.11% |
| 2020 Q3 | 1.92 Billion EUR | -49.19% |
| 2020 Q4 | 3.99 Billion EUR | 107.75% |
| 2019 Q3 | 2.31 Billion EUR | -46.86% |
| 2019 FY | 8.96 Billion EUR | 63.8% |
| 2019 Q2 | 4.36 Billion EUR | 99.5% |
| 2019 Q1 | 2.18 Billion EUR | 35.79% |
| 2019 Q4 | 4.37 Billion EUR | 88.78% |
| 2018 Q1 | 1.06 Billion EUR | -25.33% |
| 2018 Q3 | 1.6 Billion EUR | 50.84% |
| 2018 Q4 | 1.6 Billion EUR | 0.0% |
| 2018 FY | 5.47 Billion EUR | 70.39% |
| 2018 Q2 | 1.06 Billion EUR | 0.0% |
| 2017 Q3 | 1.42 Billion EUR | 72.07% |
| 2017 Q2 | 830.5 Million EUR | 0.0% |
| 2017 Q1 | 830.5 Million EUR | 13.46% |
| 2017 FY | 3.21 Billion EUR | 10.53% |
| 2017 Q4 | 1.42 Billion EUR | 0.0% |
| 2016 Q2 | 749 Million EUR | 0.0% |
| 2016 FY | 2.9 Billion EUR | 4.46% |
| 2016 Q4 | 732 Million EUR | 0.0% |
| 2016 Q3 | 732 Million EUR | -2.27% |
| 2016 Q1 | 749 Million EUR | 6.32% |
| 2015 Q4 | 704.5 Million EUR | 0.0% |
| 2015 Q2 | 714 Million EUR | 0.0% |
| 2015 Q1 | 714 Million EUR | 6.49% |
| 2015 FY | 2.78 Billion EUR | 20.02% |
| 2015 Q3 | 704.5 Million EUR | -1.33% |
| 2014 Q3 | 670.5 Million EUR | 75.52% |
| 2014 FY | 2.31 Billion EUR | 17.55% |
| 2014 Q1 | 382 Million EUR | -22.44% |
| 2014 Q4 | 670.5 Million EUR | 0.0% |
| 2014 Q2 | 382 Million EUR | 0.0% |
| 2013 Q1 | 500 Million EUR | 0.0% |
| 2013 Q2 | 500 Million EUR | 0.0% |
| 2013 Q3 | 492.5 Million EUR | -1.5% |
| 2013 Q4 | 492.5 Million EUR | 0.0% |
| 2013 FY | 1.97 Billion EUR | 1.54% |
| 2012 FY | 1.94 Billion EUR | 20.2% |
| 2011 FY | 1.61 Billion EUR | 7.48% |
| 2010 FY | 1.5 Billion EUR | 18.85% |
| 2009 FY | 1.26 Billion EUR | 2.74% |
| 2008 FY | 1.23 Billion EUR | 5.55% |
| 2007 FY | 1.16 Billion EUR | 5.89% |
| 2006 FY | 1.1 Billion EUR | 12.21% |
| 2005 FY | 981.55 Million EUR | 2.37% |
| 2004 FY | 958.83 Million EUR | 4.52% |
| 2003 FY | 917.39 Million EUR | -1.98% |
| 2002 FY | 935.93 Million EUR | 8.45% |
| 2001 FY | 862.99 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -441973.155% |
| Ansell Limited | 495.5 Million USD | -2454.591% |
| Ansell Limited | 495.5 Million USD | -2454.591% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | -15186.741% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -731256.702% |
| Psykey, Inc. | 1.21 Million USD | -1043015.667% |
| ConvaTec Group Plc | 910.31 Million USD | -1290.506% |
| ConvaTec Group Plc | 872.5 Million USD | -1350.774% |
| Encision Inc. | 3.77 Million USD | -335056.332% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -8925864.841% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -11514395.456% |
| Innovative MedTech Inc. | 6.09 Million USD | -207442.186% |
| LifePoint, Inc. | 7.42 Million USD | -170404.063% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | -199269.98% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -1480367.836% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -1743104.422% |
| Reflect Scientific, Inc. | 1.06 Million USD | -1189898.298% |
| SmileDirectClub, Inc. | 517 Million USD | -2348.342% |
| Sector 10, Inc. | 39.84 Thousand USD | -31768798.705% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | -90.545% |
| SheerVision, Inc. | 2.33 Million USD | -542780.854% |
| United Health Products, Inc. | 2.42 Million USD | -521548.323% |
| Vasamed, Inc. | 4.67 Million USD | -270780.226% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -494004.935% |
| Yubo International Biotech Limited | 1.25 Million USD | -1006200.308% |